Quality of Life and Thrombosis - Cardiovascular Update

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

JUNE 12, 2024

It enrolled 162 subjects at 30 centers with three patient populations – non-thrombotic iliac vein lesion (NIVL), post-thrombotic syndrome (PTS) and acute deep vein thrombosis (aDVT). Ultimately, the new device promises to enable excellent clinical outcomes and drive significant quality of life improvements.”

Stents

Stents Stent Anatomy Ultrasound

Case report of severe coronary artery disease complicated by malignant arrhythmia due to inherited thrombophilia

Frontiers in Cardiovascular Medicine

APRIL 8, 2025

The principal clinical manifestation of thrombophilia is venous thromboembolism, which is also markedly linked to arterial thrombosis, including myocardial infarction. The patient had a history of deep vein thrombosis and was genetically tested to carry two thrombophilia susceptibility alleles at the PAI-1 (4G/5G) and MTHFR (C>T) loci.

Coronary Artery Disease

Coronary Artery Disease Myocardial Infarction Thrombosis Quality of Life

Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial

Circulation

JANUARY 27, 2025

The risk of stent thrombosis is particularly increased during the first 6 months after intervention. Key exclusion criteria included <18 or >75 years of age, contraindications to anticoagulant use, or acute venous thrombosis <3 months. There were no differences in other outcomes or quality of life at 6 months.

Thrombosis

Thrombosis Stents Stent Quality of Life

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE)

Circulation: Cardiovascular Interventions

JANUARY 24, 2024

Principal safety outcomes were independently adjudicated International Society on Thrombosis and Haemostasis major bleeding at 72 hours post-treatment and mortality within 12 months of treatment. One patient experienced worsening of a preexisting subdural hematoma after USCDT and therapeutic anticoagulation, which ultimately required surgery.

Embolism

Embolism Thrombolysis Ultrasound Pulmonary

Application of IMB model in preventing venous thromboembolism in elderly lung cancer patients

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

The scores of the Venous Thrombosis Knowledge, Participation in Thrombosis Prevention Willingness and Behavior Questionnaire, and Quality of Life Measurement Scale (QLQ-C30) were compared before the intervention and after three months.

Cancer

Cancer Thrombosis Quality of Life Nursing

Abstract WP143: Comparative Analysis of Patient Reported Outcomes in Cerebral Venous Thrombosis and Ischemic Stroke

Stroke Journal

JANUARY 30, 2025

Introduction:The majority of patients with cerebral venous thrombosis (CVT) achieve functional independence (modified Rankin Score [mRS] 0-2), although many continue to experience residual symptoms that negatively impact quality of life. Stroke, Volume 56, Issue Suppl_1 , Page AWP143-AWP143, February 1, 2025.

Thrombosis

Thrombosis Stroke Strokes Outcomes

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

DAIC

FEBRUARY 18, 2025

Previous studies about heart valve disease have focused on procedural or device outcomes, and less on patient-centered and disease-related outcomes that are relevant to patients physical and mental well-being and quality of life.

Heart Valves

Heart Valves Quality of Life Cardiothoracic Outcomes

Abstract 4141755: New internet-based warfarin anticoagulation management approach after mechanical heart valve replacement: prospective, multicenter, randomized controlled trial

Circulation

NOVEMBER 11, 2024

However, it subjects patients to lifelong warfarin therapy after MHVR, with the attendant risk of bleeding and thrombosis. The percentage of time in the therapeutic range (TTR) was used as the primary outcome while bleeding, thrombosis, and other events were the secondary outcomes.Results:A total of 721 patients were enrolled.

Heart Valves

Heart Valves Embolism Thrombosis Quality of Life

From the Member Sections | Tackling the Polypharmacy Pandemic in CV Care

American College of Cardiology

FEBRUARY 1, 2025

Clinicians working with older patients have witnessed firsthand how polypharmacy can complicate both their care and diminish quality of life. had one or more severe potential drug-drug interaction.1 1 There has been a dramatic increase in the risk of drug-drug interactions and ADRs.

Cardiovascular Disease

Cardiovascular Disease Coronary Artery Disease CMS Hospital

Abstract 121: Misdiagnosis in a case of pediatric stroke

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

CTA/CTV of the head was done and there was no evidence of vessel abnormalities or sinus thrombosis. 60% of pediatric stroke patients will end up with disability and half will have a decreased quality of life [4]. LP was done and there was no evidence of infection. MRI of the C, T and L spine were unremarkable.

Pediatrics

Pediatrics Stroke Strokes Quality of Life

The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

DAIC

MARCH 8, 2024

Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden. However, there are shortcomings associated with LVAD implantation: complications include infection, blood clotting (thrombosis), stroke and bleeding.

Blood Clot

Blood Clot Heart Failure Quality of Life Innovation

Avocados for the Heart; Cardiology's Sad State; CBD for Pulmonary Hypertension?

Heart 2023 Conference

APRIL 20, 2022

Patients with obstructive hypertrophic cardiomyopathy who underwent surgical myectomy reported improved quality of life. The American Heart Association draws attention to nonalcoholic fatty liver disease, which affects about one in four adults and is a risk factor for atherosclerotic cardiovascular disease.

Pulmonary

Pulmonary Hypertension AFIB COVID-19

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

Case report of severe coronary artery disease complicated by malignant arrhythmia due to inherited thrombophilia

Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial

Webinars

Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE)

Application of IMB model in preventing venous thromboembolism in elderly lung cancer patients

Abstract WP143: Comparative Analysis of Patient Reported Outcomes in Cerebral Venous Thrombosis and Ischemic Stroke

Taskforce Develops New Standards to Monitor Adults with Heart Valve Disease

Abstract 4141755: New internet-based warfarin anticoagulation management approach after mechanical heart valve replacement: prospective, multicenter, randomized controlled trial

From the Member Sections | Tackling the Polypharmacy Pandemic in CV Care

Abstract 121: Misdiagnosis in a case of pediatric stroke

The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

Avocados for the Heart; Cardiology's Sad State; CBD for Pulmonary Hypertension?

Stay Connected